CURE vs NUSB
Comparison between DIREXION DAILY HEALTHCARE BULL 3X SHARES (CURE, ETF) and NUVEEN ULTRA SHORT INCOME ETF (NUSB, ETF).
CURE vs NUSB - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Net Assets
CURE
$157M
Winner
NUSB
$157M
Expense Ratio
CURE
N/A
NUSB
0.17%
Max Drawdown
CURE
69.19%
Winner
NUSB
0.61%
Sharpe Ratio
CURE
0.82
Winner
NUSB
1.47
5Y Beta
CURE
1.38
Winner
NUSB
0.00
P/E Ratio
CURE
28.04
NUSB
N/A
Forward P/E
CURE
18.09
NUSB
N/A
5Y Dividends CAGR
CURE
63.21%
NUSB
N/A
5Y EPS CAGR
CURE
12.58%
NUSB
N/A
Debt to Equity
CURE
53.58%
NUSB
N/A
P/S Ratio
CURE
1.48
NUSB
N/A
P/B Ratio
CURE
4.58
NUSB
N/A
CURE vs NUSB - Historical Returns
Returns include dividend reinvestment.
1M
Winner
CURE
+22.71%
NUSB
+0.30%
3M
CURE
-2.64%
Winner
NUSB
+0.86%
6M
Winner
CURE
+3.17%
NUSB
+1.86%
1Y
Winner
CURE
+35.83%
NUSB
+4.30%
5Y(CAGR)
CURE
+2.35%
NUSB
N/A
10Y(CAGR)
CURE
+13.12%
NUSB
N/A
Max(CAGR)
Winner
CURE
+23.37%
NUSB
+4.79%
CURE vs NUSB - Annual Returns (2011 - 2026)
Returns include dividend reinvestment.
| Year | CURE | NUSB |
|---|---|---|
| 2026 | -7.73% | +1.54% |
| 2025 | +22.87% | +4.69% |
| 2024 | -12.90% | +4.50% |
| 2023 | -8.46% | N/A |
| 2022 | -17.91% | N/A |
| 2021 | +90.55% | N/A |
| 2020 | +4.13% | N/A |
| 2019 | +62.36% | N/A |
| 2018 | -0.75% | N/A |
| 2017 | +62.77% | N/A |
| 2016 | -12.42% | N/A |
| 2015 | +6.24% | N/A |
| 2014 | +83.03% | N/A |
| 2013 | +153.15% | N/A |
| 2012 | +45.79% | N/A |
| 2011 | -9.68% | N/A |
CURE vs NUSB Drawdown Comparison
The maximum drawdown for CURE was -69.19%, occurring on Mar 23, 2020. Recovery took 242 trading sessions.
The maximum drawdown for NUSB was -0.16%, occurring on Apr 10, 2025. Recovery took 12 trading sessions.
The current CURE drawdown is -25.85%.
| Rank | CURE | NUSB |
|---|---|---|
| #1 | -69.19% Jan 22, 2020 - Jan 6, 2021 | -0.16% Apr 1, 2025 - Apr 17, 2025 |
| #2 | -52.25% Apr 8, 2022 - Aug 7, 2025 | -0.06% Mar 9, 2026 - Mar 23, 2026 |
| #3 | -48.54% Jul 20, 2015 - Jun 22, 2017 | -0.06% Jun 30, 2025 - Jul 3, 2025 |
| #4 | -44.44% Jul 1, 2011 - Mar 15, 2012 | -0.04% Mar 11, 2024 - Mar 19, 2024 |
| #5 | -42.27% Oct 1, 2018 - Nov 27, 2019 | -0.04% Apr 4, 2024 - Apr 15, 2024 |
| #6 | -36.35% Jan 26, 2018 - Sep 13, 2018 | -0.04% Oct 2, 2024 - Oct 11, 2024 |
| #7 | -29.28% Dec 30, 2021 - Apr 8, 2022 | -0.04% Jul 3, 2025 - Jul 11, 2025 |
| #8 | -22.89% Aug 17, 2021 - Dec 15, 2021 | -0.04% Mar 25, 2026 - Mar 30, 2026 |
| #9 | -22.59% Sep 24, 2014 - Oct 28, 2014 | -0.04% Jul 14, 2025 - Jul 18, 2025 |
| #10 | -19.78% Mar 4, 2014 - Jun 19, 2014 | -0.04% Oct 21, 2024 - Oct 25, 2024 |
| #11 | -19.31% Oct 17, 2012 - Jan 9, 2013 | -0.04% Sep 8, 2025 - Sep 12, 2025 |
| #12 | -19.31% Jan 20, 2021 - Apr 15, 2021 | -0.04% May 27, 2025 - May 30, 2025 |
| #13 | -17.38% Apr 2, 2012 - Jun 29, 2012 | -0.02% Feb 27, 2026 - Mar 6, 2026 |
| #14 | -15.49% May 28, 2013 - Jul 12, 2013 | -0.02% Aug 2, 2024 - Aug 9, 2024 |
| #15 | -14.96% Dec 8, 2014 - Jan 22, 2015 | -0.02% Jan 3, 2025 - Jan 8, 2025 |
Correlation
Correlation between CURE and NUSB is -0.42 which considered as a weak negative correlation - the stocks show a slight tendency to move in opposite directions.
-0.42
-101
Dividend Comparison (2011 - 2026)
CURE vs NUSB dividend yield comparison.
| Year | CURE | NUSB |
|---|---|---|
| 2026 | 0.27% | 1.63% |
| 2025 | 1.12% | 4.51% |
| 2024 | 1.17% | 3.61% |
| 2023 | 2.02% | 0.00% |
| 2022 | 0.38% | 0.00% |
| 2021 | 0.02% | 0.00% |
| 2020 | 0.17% | 0.00% |
| 2019 | 0.40% | 0.00% |
| 2018 | 0.70% | 0.00% |
| 2017 | 0.18% | 0.00% |
| 2013 | 1.24% | 0.00% |
| 2012 | 0.03% | 0.00% |
| 2011 | 2.10% | 0.00% |
Select Stocks to Compare
Popular: CURE vs SPYNUSB vs SPY
More Comparisons
Compare with similar stocks